Becton Dickinson & Co
BDX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| Tq< | LOCK|@s%f | LOCK|N$b |
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters
Waters and BD have agreed to combine BD's biosciences and diagnostics unit with Waters. BD will receive $4 billion in cash and a 39.2% stake in the combination. The deal is scheduled to close in the first quarter of 2026. In early trading, Waters shares were down 11% and BD's were down 1%.
